dc.contributor.author | Tang, Hsin-Chieh | |
dc.contributor.author | Chen, Calvin Yu-Chian | |
dc.date.accessioned | 2015-03-20T13:35:23Z | |
dc.date.available | 2015-03-20T13:35:23Z | |
dc.date.issued | 2014-02 | |
dc.date.submitted | 2013-12 | |
dc.identifier.issn | 1741-427X | |
dc.identifier.issn | 1741-4288 | |
dc.identifier.uri | http://hdl.handle.net/1721.1/96103 | |
dc.description.abstract | Knowing the role of MC1R in skin tanning can provide a brand new idea to resolve pigmentary disorders. αMSH has 13 amino acids and is the most essential pigmentary melanocortin responsible for melanin synthesis. One could utilize the compound library to find lead compounds by virtual screening from peptide database and traditional Chinese medicine (TCM) database@Taiwan. Computational simulation provided a convenient technology to survey potential lead. Ligand-based validation set up the reliable model for molecular dynamics simulation. Molecular dynamics simulation approved the binding affinity and stability of the peptides selected by virtual screening. Thus, we concluded that Glu-Glu-Lys-Glu (EEKE), Glu-Gly-Gly-Ser-Val-Glu-Ser (EGGSVES), and Glu-Glu-Asp-Cys-Lys (EEDCK) were potent lead peptides for MC1R to resolve pigmentary disorders. | en_US |
dc.description.sponsorship | National Science Council of Taiwan (Grant NSC102-2325-B039-001) | en_US |
dc.description.sponsorship | National Science Council of Taiwan (Grant NSC102-2221-E-468-027) | en_US |
dc.description.sponsorship | Asia University (Grant ASIA101-CMU-2) | en_US |
dc.description.sponsorship | Asia University (Grant 102-Asia-07) | en_US |
dc.description.sponsorship | China Medical University Hospital (Grant DMR-103-001) | en_US |
dc.description.sponsorship | China Medical University Hospital (Grant DMR-103-058) | en_US |
dc.description.sponsorship | China Medical University Hospital (Grant DMR-103-096) | en_US |
dc.publisher | Hindawi Publishing Corporation | en_US |
dc.relation.isversionof | http://dx.doi.org/10.1155/2014/254678 | en_US |
dc.rights | Creative Commons Attribution | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by/2.0 | en_US |
dc.source | Hindawi Publishing Corporation | en_US |
dc.title | Investigation of the Novel Lead of Melanocortin 1 Receptor for Pigmentary Disorders | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Tang, Hsin-Chieh, and Calvin Yu-Chian Chen. “Investigation of the Novel Lead of Melanocortin 1 Receptor for Pigmentary Disorders.” Evidence-Based Complementary and Alternative Medicine 2014 (2014): 1–13. | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Computational and Systems Biology Program | en_US |
dc.contributor.mitauthor | Chen, Calvin Yu-Chian | en_US |
dc.relation.journal | Evidence-Based Complementary and Alternative Medicine | en_US |
dc.eprint.version | Final published version | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dc.date.updated | 2015-03-19T11:33:45Z | |
dc.language.rfc3066 | en | |
dc.rights.holder | Copyright © 2014 Hsin-Chieh Tang and Calvin Yu-Chian Chen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | |
dspace.orderedauthors | Tang, Hsin-Chieh; Chen, Calvin Yu-Chian | en_US |
mit.license | PUBLISHER_CC | en_US |
mit.metadata.status | Complete | |